4/A//SEC Filing
Piper Brian 4/A
Accession 0001192482-18-000224
CIK 0001138776other
Filed
May 15, 8:00 PM ET
Accepted
May 16, 4:36 PM ET
Size
6.1 KB
Accession
0001192482-18-000224
Insider Transaction Report
Form 4/AAmended
Piper Brian
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Purchase)
2017-08-11+110,000→ 110,000 totalExercise: $1.32Exp: 2027-08-11→ Common Stock (110,000 underlying)
Footnotes (2)
- [F1]The option award vests and becomes exercisable as follows (rounded up to the nearest whole share of common stock): one-third on August 11, 2018, then in 24 equal monthly installments on the 11th day of each subsequent calendar month, subject to the reporting person's continued service with the issuer.
- [F2]Reflects a reduction in the number of shares purchaseable under the stock option. A portion of the originally granted amount was void due to having exceeded certain plan limitations.
Documents
Issuer
Aevi Genomic Medicine, Inc.
CIK 0001138776
Entity typeother
Related Parties
1- filerCIK 0001665924
Filing Metadata
- Form type
- 4/A
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 4:36 PM ET
- Size
- 6.1 KB